U.S. Other Utilities Stock News

NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Incyte (INCY) Stock Rallies As Profit Strength Fuels Diversification Debate

Incyte stock just jumped 9.3% in a single session, yet the real story is not the share price spike. The company delivered what the market has been waiting for in biotech, with revenue for Q2 2026 reaching US$1.67b and basic earnings per share at US$2.92. The one day move reflects investors suddenly pricing in a business that now appears more profitable and more diversified than it did even a few quarters ago. Impressed by Incyte’s Q2 2026 earnings strength but want more stocks that pair solid...
NasdaqGS:FIBK
NasdaqGS:FIBKBanks

Stronger Earnings and Larger Buyback Authorization Might Change The Case For Investing In First Interstate BancSystem (FIBK)

In July 2026, First Interstate BancSystem reported second-quarter 2026 net income of US$83.9 million and diluted earnings per share of US$0.87, while also disclosing higher net loan charge-offs of US$9.7 million and announcing a US$0.47 quarterly dividend. Over the same period, the board completed a share repurchase of approximately 7.98 million shares and expanded its buyback authorization to US$450 million, signalling continued use of capital returns alongside board refreshment with two...
NYSE:M
NYSE:MMultiline Retail

Macy’s (M) Is Up 5.7% After Zacks Upgrade And Bluemercury Leadership Move - What’s Changed

Recent coverage in July 2026 highlighted that Macy’s is now rated a Zacks Rank #1 (Strong Buy), with earnings estimates revised higher and valuation metrics such as P/E, P/B and P/CF suggesting the stock is trading at an attractive discount to industry peers. At the same time, Macy’s appointment of Alexandre Choueiri to lead Bluemercury is reshaping how investors view its presence in prestige beauty and the company’s overall business mix. We’ll now examine how Macy’s perceived...
NasdaqGS:IRTC
NasdaqGS:IRTCMedical Equipment

iRhythm Holdings (IRTC) Could Be 34% Undervalued Following Its Recent Rebound

iRhythm Holdings (IRTC) is back on investor radars after recent trading, with the stock closing at US$117.37. The move comes against a backdrop of mixed short and longer term share price performance. See our latest analysis for iRhythm Holdings. The strong 1 day share price return of 4.65% and 7 day share price return of 7.68% come after a weaker run, with the year to date share price return down 33.02% and the 1 year total shareholder return down 14.18%. However, the 5 year total shareholder...
NYSE:MCB
NYSE:MCBBanks

Does Metropolitan Bank Holding (MCB) Raising Its Dividend Reflect Strategic Confidence or Limited Reinvestment Options?

Metropolitan Bank Holding Corp. recently reported its second-quarter 2026 results, with net interest income rising to US$90.45 million and net income edging up to US$19.22 million, while basic earnings per share from continuing operations eased to US$1.55 from US$1.78 a year earlier. Across the first half of 2026, the bank’s net income increased to US$50.65 million and diluted earnings per share from continuing operations reached US$4.40, alongside a board-approved quarterly dividend...
NYSE:HSY
NYSE:HSYFood

Hershey Stock And Other Staples Picks For Investors Seeking Steadier Ground

Tech stocks are under pressure after a sharp global semiconductor sell off, yet many investors are looking at the other side of their portfolios. Large consumer staples stocks can sometimes offer a steadier ride when chip stocks swing sharply. This article focuses on three companies from a Defensive Consumer Staples Stocks screener that appear closely exposed to the current news backdrop, whether through their role in everyday spending or their perceived lower risk profile. You will see how...
NasdaqCM:OTLK
NasdaqCM:OTLKBiotechs

Outlook Therapeutics (OTLK) Is Down 36.3% After First FDA‑Approved Ophthalmic Bevacizumab Win - What's Changed

Outlook Therapeutics recently received U.S. FDA approval for LYTENAVA (bevacizumab‑vikg) to treat neovascular (wet) age-related macular degeneration, making it the first and only FDA‑approved ophthalmic bevacizumab in the U.S. retina market. This approval, which the company believes qualifies LYTENAVA for 12 years of Reference Product Exclusivity under the Biologics Price Competition and Innovation Act, positions Outlook Therapeutics in an approximately US$8.50 billion annual U.S. anti‑VEGF...
NYSE:EVR
NYSE:EVRCapital Markets

How Evercore’s Q2 2026 Beat‑Rate Narrative Could Shape Sentiment for EVR Investors

Evercore Inc. reported its Q2 2026 results on July 29, 2026, holding its earnings call the same day after releasing numbers before the US market opened. The market’s focus is on Evercore’s upcoming revenue growth expectations and its history of outperforming analyst estimates, which together are shaping sentiment ahead of this earnings season. We’ll now explore how Evercore’s upcoming Q2 earnings report and history of beating expectations could influence its broader investment...
NYSE:AMG
NYSE:AMGCapital Markets

Does AMG's Q2 2026 EBITDA Guidance Subtly Recast Its Risk‑Reward Narrative?

Affiliated Managers Group recently issued guidance for its second-quarter 2026 results, indicating an adjusted EBITDA range of US$290 million to US$305 million and highlighting continued strength in its earnings surprise track record. The company’s current Zacks Rank #2 (Buy) and positive Earnings ESP of 1.86% have reinforced investor focus on how its diversified affiliates may sustain performance. We’ll now examine how AMG’s guided adjusted EBITDA range for the quarter may influence its...
NasdaqGS:SYNA
NasdaqGS:SYNASemiconductor

Synaptics (SYNA) Stock May Be Fully Priced On Cash Flow Yet A Bargain On Sales

Synaptics stock has delivered a strong 70.9% return over the past year, yet its valuation picture is split, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to a premium while traditional market multiples suggest the shares may still be priced attractively. Over the past 12 months Synaptics has returned 70.9%, which places recent share price momentum firmly on the positive side for existing holders. Future growth in cash flows from Synaptics' semiconductor solutions can...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

How Investors May Respond To Astronics (ATRO) Winning A Favorable UK Patent Ruling And Refund

Astronics Corporation recently received a favorable ruling from a UK appellate court in its patent dispute with Lufthansa Technik AG, which dismissed Lufthansa Technik’s appeal and ordered a partial refund to Astronics. This court outcome not only returns cash to Astronics but also strengthens the company’s legal position around its intellectual property protection efforts. We’ll now examine how this favorable patent ruling, including the ordered partial refund, reshapes Astronics’ existing...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

The Bull Case For Zions Bancorporation (ZION) Could Change Following Debt Issue, Earnings Beat, Buybacks Completion

Zions Bancorporation, National Association recently completed a US$500,000,000 fixed-to-floating rate senior note offering due October 1, 2029, while also reporting second-quarter 2026 results that showed higher net interest income and net income versus the prior year. Alongside this earnings strength, Zions finished a US$75,000,000 share repurchase program in the quarter, signaling active balance sheet and capital management. With these stronger quarterly earnings and completed buybacks,...
NasdaqGM:FGBI
NasdaqGM:FGBIBanks

First Guaranty Bancshares (FGBI) Stock Rebounds While Credit Risk Still Shapes The Story

First Guaranty Bancshares stock inched up about 3% to US$9.64 after its second quarter report, a modest move for a bank that has put investors through sharp swings over the past year. The market reaction looks calm on the surface, yet the headline is more dramatic. Earnings per share landed at roughly US$0.17 and net income reached about US$2.8 million, while non performing loans continued to weigh on the story. The key issue is how long this repair job on credit quality and profitability can...
NasdaqGS:IDCC
NasdaqGS:IDCCSoftware

InterDigital (IDCC) Stock Looks Undervalued Despite New 6G Focus

InterDigital stock has delivered a very large 5 year return, yet the latest valuation checks paint a more mixed picture, which raises questions about how much of that progress is already reflected in the current price. Over the past 5 years, InterDigital shares have gained about 308%, which puts long term holders in a strong position but makes the current entry point more sensitive to valuation assumptions. Recent moves to extend its patent licensing into connected EV chargers and highlight...
NasdaqGM:AAOI
NasdaqGM:AAOICommunications

Applied Optoelectronics (AAOI) Stock Looks Cheap On Cash Flow While Sales Look Rich

Applied Optoelectronics stock has delivered an extremely strong three year return, yet current valuation work suggests the market price may still sit below an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and supported by earnings multiples. Over the past three years, Applied Optoelectronics has returned about 11x, which puts a lot of focus on whether that gain is justified by the company’s long term cash generation potential. Future revenue growth and cash flow...
NYSE:ETN
NYSE:ETNElectrical

Eaton (ETN) Stock May Be Overvalued After Its 157% Five Year Run

Eaton stock has returned 156.9% over the past five years, yet the latest valuation checks send a mixed signal, with the Discounted Cash Flow (DCF) intrinsic value suggesting the shares trade at a premium while the earnings multiple view appears more supportive. A 156.9% gain over five years highlights how strongly Eaton has rewarded long term holders, which raises the bar for what counts as good value today. Recent moves to expand additive manufacturing in Europe and sharpen focus on energy...
NYSE:SSD
NYSE:SSDBuilding

Simpson Manufacturing (SSD) Stock Gains Ground On Margin Strength

Simpson Manufacturing stock shrugged off its recent 30 day slump, rising 2.6% today, because the quarter landed squarely on the one thing this housing exposed manufacturer is increasingly being judged on: profitability. Q2 net sales reached US$671.1m, but the real story was earnings power, with net income of US$127.0m and an operating margin of 25.2% that leaned on tight cost control and mix rather than volume. For a company often viewed as a steady building products supplier, this kind of...
NYSE:UPS
NYSE:UPSLogistics

UPS (UPS) Stock Sinks As Volume Weakness Clouds Margin Gains

The market punished United Parcel Service on the earnings print. The stock dropped about 7% to around US$105, even though the quarter showed the kind of margin story investors usually want from a delivery heavyweight. Adjusted operating profit climbed to about US$2.1b on US$22.8b of revenue, and the consolidated operating margin reached 9.2%. For a company often treated as a slow freight barometer rather than a profit engine, this margin rebuild is the headline. Management also raised full...
NYSE:BG
NYSE:BGFood

Bunge (BG) Stock Looks Reasonable On Earnings But Rich On Returns

Bunge Global stock has delivered a strong 73.9% total return over the past five years, yet the valuation checks point to a mixed picture rather than a clear bargain or clear overvaluation at the current price of US$117.37. The 73.9% return over five years suggests Bunge Global has rewarded long term shareholders, which puts more focus on whether the current price still offers an attractive entry point. Expectations for steady cash generation from its agricultural and food operations can...
NYSE:MAN
NYSE:MANProfessional Services

ManpowerGroup (MAN) Is Up 7.2% After Q2 Return To Profitability And Detailed EPS Guidance

In July 2026, ManpowerGroup reported second-quarter results showing a return to profitability, with net income of US$53.5 million and diluted earnings per share from continuing operations of US$1.13, and issued third-quarter 2026 guidance for diluted earnings per share of US$0.96 to US$1.06, including an estimated US$0.02 unfavorable currency impact and a 44% effective tax rate. An interesting angle for investors is that this shift from a loss a year ago to positive earnings, alongside...
OTCPK:KTHN
OTCPK:KTHNBanks

Katahdin Bankshares (KTHN) Stock Looks Cheap As Margins Stay Firm

Katahdin Bankshares stock inched up about 2.3% to US$36 after the Q2 release, a calm move for a community bank that just reported another quarter of solid profitability. The headline is simple: earnings held up and the valuation gap stayed wide. Trailing earnings per share sit at US$3.37 with a trailing P/E of 10.7x, while net profit margin is 24.1%. For short term traders, today’s uptick may feel modest. For longer term investors, the bigger question is whether a bank earning these margins...
NYSE:NU
NYSE:NUBanks

3 Financial Stocks With Earnings Growth As Rate Cut Hopes Fade

Surging oil prices, renewed conflict in Iran and fresh speculation about a surprise Federal Reserve rate hike are putting the Banking and Financial Sector Stocks screener firmly in the spotlight. Higher inflation risks and shifting interest rate expectations can reshape funding costs, loan demand and trading conditions for large, financially healthy banks and diversified financial companies. For investors watching how macro shocks filter through to individual stocks, this screener helps flag...
NYSE:ABG
NYSE:ABGSpecialty Retail

Asbury Automotive Group (ABG) Stock Jumps As Profit Squeeze Meets Tekion Optimism

Asbury Automotive Group stock jumped 6.3% to about US$241 into the close, which indicates investors chose excitement over caution on this print. The headline is a profit squeeze. Q2 basic earnings per share came in at US$6.26 and net income was US$114.6m on US$4.38b of revenue. That is a lighter earnings haul than recent quarters for this auto retailer, even as the business leans on its technology rollout story. Today the market rewarded the transition narrative more than the compressed...
NYSE:AEM
NYSE:AEMMetals and Mining

Agnico Eagle (AEM) Stock Still Looks Undervalued After A 200% Run

Agnico Eagle Mines has returned about 200.5% over the past three years, yet current valuation checks still point to the stock trading at a discount to an intrinsic value estimate based on a Discounted Cash Flow (DCF) approach and market multiples. That combination of strong past returns and an undervalued read on both cash flow and earnings raises the question of how much upside, if any, might still be left in the current share price. A roughly 200.5% return over three years suggests Agnico...